ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction

Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.

Circulation·2026

Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.

Journal of the American College of Cardiology·2026

Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.

American heart journal·2026

Cost-effectiveness of imaging modalities in coronary heart disease: A comprehensive review.

Seminars in nuclear medicine·2026

Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.

Diabetes care·2026

Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

Circulation·2026

Coronary Revascularization of Ischemic Territories Improves Myocardial Perfusion, Increases Submaximal Aerobic Capacity and Reduces Exercise-Induced Angina in Patients with Chronic Coronary Syndrome.

The American journal of cardiology·2026

The Cancer-Associated Lipid Paradox: Implications for Cardiovascular Risk and Lipid Management.

The American journal of cardiology·2026

Safe and Fast Radial Artery Hemostasis Using Synergistic Strategies: SAFE and FAST Trial.

The American journal of cardiology·2026

Coronary Aneurysmal and Ectatic Disease: Cath-Lab Diagnosis and Contemporary Interventional Management.

The American journal of cardiology·2026

Early Aspirin Discontinuation vs 12-Month Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials.

The American journal of cardiology·2026

Racial and Ethnic Differences in Transcatheter Coarctation Repair Among Adolescents and Adults.

The American journal of cardiology·2026

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

JACC. Heart failure·2026

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

European journal of preventive cardiology·2026

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Polish archives of internal medicine·2026

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026

Related Experiment Videos

ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction

Related Concept Videos

Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.

Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.

Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.

Cost-effectiveness of imaging modalities in coronary heart disease: A comprehensive review.

Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.

Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

Coronary Revascularization of Ischemic Territories Improves Myocardial Perfusion, Increases Submaximal Aerobic Capacity and Reduces Exercise-Induced Angina in Patients with Chronic Coronary Syndrome.

The Cancer-Associated Lipid Paradox: Implications for Cardiovascular Risk and Lipid Management.

Safe and Fast Radial Artery Hemostasis Using Synergistic Strategies: SAFE and FAST Trial.

Coronary Aneurysmal and Ectatic Disease: Cath-Lab Diagnosis and Contemporary Interventional Management.

Early Aspirin Discontinuation vs 12-Month Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials.

Racial and Ethnic Differences in Transcatheter Coarctation Repair Among Adolescents and Adults.

Ex Vivo Perfusion Unmasks a Proteomic Signature of Primary Graft Dysfunction in Donor Hearts.

Thrombin-Antithrombin Complexes and sICAM-1 Are Associated With In-Hospital Mortality in COVID-19 Patients With Inflammatory Storm.

CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.

Medication persistence and mortality in ST-elevation myocardial infarction patients with and without standard modifiable risk factors: a SWEDEHEART registry study.

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

Anticoagulation in Advanced Chronic Kidney Disease: Navigating Uncertainty.

Related Experiment Videos

ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction

Related Concept Videos

Related Articles